Telcon RF Pharmaceutical Inc (200230) Stock Price & News

200230:KOSDAQ

Telcon RF Pharmaceutical Inc

₩2,220.00

-1.99%

(-45.00) 1D

Oct 12, 3:30:30 PM GMT+9 · KRW

All symbols

	Symbol	Price	Change	% Change

Generating top insights for 200230...

Open

₩2,240

High

₩2,250

Low

₩2,175

Mkt. cap

21.05B

Avg. vol.

16.06K

Volume

8.96K

52-wk high

₩13,210

52-wk low

₩1,700

EPS

-₩4,260

Shares outstanding

9.48M

No. of employees

119

Open

₩2,240

High

₩2,250

Low

₩2,175

Mkt. cap

21.05B

Avg. vol.

16.06K

Volume

8.96K

52-wk high

₩13,210

52-wk low

₩1,700

EPS

-₩4,260

Shares outstanding

9.48M

No. of employees

119

Related stocks

Sam Chun Dang Pharm Co Ltd

₩212,500.00

-12.73%

009420

Hanall Biopharma Co Ltd

₩43,150.00

-1.93%

News stories

From web sources and news partners

TradingView

28 minutes ago

Michael Burry Shifts Bearish Bets To Nasdaq, Semiconductor ETF Puts — Sees Market Top Within 9 Months

StockStory

28 minutes ago

2 S&P 500 Stocks to Own for Decades and 1 We Find Risky

Bloomberg.com

43 minutes ago

Oil Rises on Mideast Attacks, Dollar Edges Higher: Markets Wrap

Yahoo Finance

5 hours ago

Dow, S&P 500, Nasdaq Futures Climb After Oil In Focus As Trump Declares ‘Energy Ceasefire’ Between Russia And Ukraine: IREN, WFF, VSTM, CIFR Stocks In Focus

About Telcon RF Pharmaceutical Inc

CEO-

Employees119

Founded1999

Headquarters-

SectorElectronics manufacturing services

Websitetelcon.co.kr

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	9.82B	13.32B	9.70B	28.94B
Cost of goods sold	7.46B	8.86B	7.99B	15.98B
Cost of revenue	7.46B	8.86B	7.99B	15.98B
Research and development expenses	200.93M	121.08M	158.40M	199.91M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	1.36B	1.21B	1.99B	12.26B
Operating expense	2.37B	1.84B	3.14B	13.76B
Total operating expenses	9.83B	10.70B	11.13B	29.74B
Operating income	-8.66M	2.63B	-1.43B	-805.54M
Other non operating income	-869.79M	9.17B	18.61M	6.99B
EBT including unusual items	-4.85B	9.85B	-11.47B	-20.58B
EBT excluding unusual items	-3.30B	8.87B	-1.71B	12.35B
Income tax expense	-	-	-	-52.41M
Effective tax rate	-	-	-	0.25%
Other operating expenses	234.90M	-117.50M	42.37M	185.39M
Net income	-4.88B	9.85B	-11.47B	-10.98B
Net profit margin	-49.71%	73.94%	-118.22%	-37.95%
Earnings per share	-	-	-	-
Interest and investment income	161.64M	187.99M	330.99M	324.98M
Interest expense	-1.05B	-889.39M	-905.78M	-1.11B
Net interest expenses	-885.28M	-701.40M	-574.79M	-784.98M
Depreciation and amortization charges	101.59M	101.59M	94.48M	398.23M
EBITDA	1.18B	4.05B	-246.72M	1.31B
Gain or loss from assets sale	-486.92M	-	-34.99M	287.10M

Ask anything